美国银行和HC Wainwright提高Travere治疗公司股票的目标价格。 Bank of America and HC Wainwright raise target prices for Travere Therapeutics' stock.

美国银行将Travere Therapeutics的目标价格从18美元提高到19美元, 而HC Wainwright则将其从20美元提高到23美元, 保持"购买"评级. Bank of America has increased its target price for Travere Therapeutics (NASDAQ: TVTX) from $18 to $19, while HC Wainwright raised theirs from $20 to $23, maintaining a "buy" rating. 股票的共识评级为"中等买入",平均目标价为16.92美元. The stock has a consensus rating of "Moderate Buy" and an average target price of $16.92. 近期收入损失惨重,股本收益为 - 269.18%。 Recent earnings showed significant losses, with a return on equity of -269.18%. 内部交易活动包括过去90天出售30 707股,价值352 712美元。 Insider trading activity included the sale of 30,707 shares worth $352,712 in the last 90 days.